Axentis Pharma is a Swiss-based pharmaceutical company focused on chronic lung diseases and respiratory related disorders, especially on cystic fibrosis. Axentis Pharma is solely financed by private investors. The company is currently looking for co-development and co-marketing partners in the respiratory arena with the goal to create a competence center for healthcare professionals and patients in the company’s domestic markets.
